Center for Lawful Access and Abuse Deterrence
Nonprofit profile at a glance
- EIN
- 272876027
- IRS 990 coverage
- 2010–2018
- Forms available
- Form 990 2018
- Location
- Washington, DC, USA
- Rating
- 65
- Verdict
- SUPPORTED
- Rating confidence
- Moderate
- Sector
- Alcohol, Drug Abuse, Prevention Only
Reported finances
- Revenue
- $30,021
- Expenses
- $34,139
- Assets
- $0
- Liabilities
- $0
Source: IRS Form 990. Selected filing: tax year 2018. Amounts in USD.
Leadership & pay
5 people listed
People named in this filing
- Alex Cahana MD (Director)
- Shari Hicks (Director)
- Wade Delk (Director)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990. Selected filing: tax year 2018. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) worked to reduce prescription drug fraud, diversion, misuse, and abuse while advancing consumer access to high-quality care for pain, addiction, HIV, hepatitis C, and other health conditions. CLAAD enabled health professionals, law enforcement, businesses, government officials, and others to share resources and work together to improve public health and safety. It fostered collaboration among the multiple sectors of society that had previously been working concurrently, yet not in unison, to address the growing national concern for prescription drug abuse. CLAAD gathered information and research on prescription drug abuse, misuse, and diversion. It coordinated grassroots activities among interested organizations and made policy recommendations on prescription drug abuse with the goal of improving public health.
What it reported doing in 2018
Information and analysis. CLAAD monitored legislation, policy making, scientific research, and current events related to prescription drug abuse and access to health care. It disseminated this information through the News section of its website, at national conferences and symposia, and via online forums, such as Twitter and LinkedIn. CLAAD spokespersons and coalition members provided analysis in the media as documented in the "CLAAD in the Media" section of its website. CLAAD began winding down these activities in the first quarter of 2018 and dissolved in April of 2018.
Operating model
- Revenue model
- Donor-supported. 100% of the money available for current operations came from contributions and gifts.
- Distribution model
- Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.
The verdict
SUPPORTED - A large share of available resources goes toward mission work and the filed numbers largely add up. Some filing-based governance responses are negative or unanswered and program spending has declined or grown slowly.
Rating breakdown
- Financial Efficiency: 77
- Transparency & Controls: 92
- Accountability: 24
- Sustainability: 28
- Growth: 0
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 91.4%; rating input score 91
- Program expense ratio: 80.4%; rating input score 80
- Fundraising efficiency: Limited
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 62nd percentile among comparable filings
- Pay-setting controls: Limited
- Foreign activity oversight: Limited
- Grant itemization coverage: Limited
- Major donor itemization: Yes; rating input score 100
- Related-party transparency: Limited
Accountability
- Independent voting board: Limited
- Governance controls: 4 of 7 controls in place; rating input score 57
- Conflict-of-interest policy: Pass
- Whistleblower policy: Pass
- Document-retention policy: Pass
- CEO compensation review process: NotApplicable
- Other executive compensation review process: NotApplicable
- Form 990 shared with the board: Fail
- Board meeting minutes documented: Pass
- Audit committee oversight: Missing
- Independent financial-statement audit: Fail
Sustainability
- Operating margin: -13.7%; rating input score 43; 43rd percentile among comparable filings
- Total-asset coverage ratio: 0; rating input score 2; 2nd percentile among comparable filings
- Liabilities to assets ratio: Limited
- Officer compensation ratio: 0%; rating input score 61; 61st percentile among comparable filings
Growth
- Program expense growth: -17.5% per year; rating input score 0; 24th percentile among comparable filings
- Revenue growth: -8.9% per year; rating input score 0; 37th percentile among comparable filings
- Asset growth: -19.6% per year; rating input score 0; 10th percentile among comparable filings
Details
- Where the money goes: 91.4% of revenue deployed · 80.4% of spending went to programs
- Governance: 4 of 7 filing controls reported
- Programs: 3 filed program accomplishments · $27K in reported program spending
- Leadership: top reported pay $0 · 5 people listed
- Consistency: 19 of 19 current checks pass
- Schedules: 5 filed schedules · includes major donors
- Filing history: 9 filing years from 2010 to 2018
- Contacts: How to reach this organization
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
Grant-readiness screening is separate from the live rating, not a measure of program quality. Review the source records before making a grant decision.
- Review — Accountability: Governance controls: 2 of 6 not reported.
- High — Growth: Program expense growth scored 0/100.
- High — Growth: Revenue growth scored 0/100.
- High — Sustainability: Total-asset coverage ratio scored 2/100.
- Moderate — Sustainability: Operating margin scored 43/100.
- High — Growth: Asset growth scored 0/100.
- High — Grant Readiness: Automatic revocation: this organization had its federal tax-exempt status automatically revoked.